Smithfield Trust CO Nektar Therapeutics Transaction History

Smithfield Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $2,425 - $4,123	-224 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$16.59 - $24.79 $1,974 - $2,950	119 Added 113.33%	224 $4,000
Q2 2020 Aug 14, 2020	BUY	$16.86 - $23.44 $1,770 - $2,461	105 New	105 $2,000
Q1 2020 May 05, 2020	SELL	$14.47 - $27.96 $1,808 - $3,495	-125 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$15.87 - $23.12 $1,587 - $2,312	-100 Reduced 44.44%	125 $3,000
Q3 2019 Oct 30, 2019	BUY	$16.91 - $36.27 $1,691 - $3,627	100 Added 80.0%	225 $4,000
Q4 2017 Feb 02, 2018	BUY	$23.02 - $60.5 $2,877 - $7,562	125	125 $7,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

Stay updated on Smithfield Trust CO with notifications on news.